Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Phase I Study of Bortezomib Combined with Lenalidomide for Relapsed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Following Hematopoietic Cell Transplantation

Andrew M. Brunner, MD, Traci M. Blonquist, MS, Malgorzata McMasters, MD, Gabriela S. Hobbs, MD, Steven L McAfee, MD, Jacalyn Rosenblatt, MD, Philip C. Amrein, MD, Areej El-Jawahri, MD, Christine Connolly, Aura Ramos, Kaleb Mikami, Emma Logan, Bimalangshu R Dey, MD PhD, Thomas Spitzer, MD, David E. Avigan, MD, Amir T. Fathi, MD MD BS, Yi-Bin Chen, MD, Karen Ballen, MD

Blood (2017) 130 (Supplement 1): 3280.

https://doi.org/10.1182/blood.V130.Suppl_1.3280.3280

Published: 2017

Journal Articles

Bortezomib-Based Versus Standard of Care Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation: A Phase II Randomized Controlled Trial

John Koreth, MD, Haesook T. Kim, PhD, Paulina B Lange, Philippe Armand, MD PhD, Corey S. Cutler, MD MPH, Vincent T. Ho, MD, Brett Glotzbecker, MD, Rushdia Z. Yusuf, MBBS, MPH, Sarah Nikiforow, MD PhD, Bimalangshu R. Dey, MD PhD, Malgorzata McMasters, MD, Jerome Ritz, MD, Bruce R. Blazar, MD, Robert J. Soiffer, MD, Joseph H Antin, MD, Edwin P. Alyea, MD

Blood (2016) 128 (22): 508.

https://doi.org/10.1182/blood.V128.22.508.508

Published: 2016

Journal Articles

Hematopoietic Stem Cell Transplantation in the Resource-Limited Setting: Establishing the First Bone Marrow Transplant Unit in Bangladesh and Initial Outcomes

Blood (2016) 128 (22): 2384.

https://doi.org/10.1182/blood.V128.22.2384.2384

Published: 2016

Journal Articles

Hematopoeitic Stem Cell Transplantation in the Developing World: A Case Study of Dhaka Medical College, Bangladesh

Albert C. Yeh, MD, Bimalangshu R. Dey, MD PhD, Thomas R. Spitzer, MD, Mafruha Akter, FCPS,MBBS, Akhil Biswas, MBBS, Mohiuddin Ahmed Khan, FRCP,MBBS, Tasneem Ara, MBBS, Jannatul Ferdous, MBBS, Salma Aforse, MBBS, Manirul Islam, MBBS

Blood (2015) 126 (23): 5626.

https://doi.org/10.1182/blood.V126.23.5626.5626

Published: 2015

Journal Articles

Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation

Areej El-Jawahri, MD, Lara Traeger, PhD, Kailyn Kuzmuk, B.A., Justin Eusebio, B.S., Harry Vandusen, B.S., Jennifer Shin, MD, Emily Gallagher, RN, Joseph Greer, PhD, William Pirl, MD, Vicki Jackson, MD, Karen K. Ballen, MD, Thomas R. Spitzer, MD, Timothy A. Graubert, MD, Steven L. McAfee, MD, Bimalangshu R. Dey, MD PhD, Yi-Bin Chen, MD, Jennifer S. Temel, MD

Blood (2014) 124 (21): 1296.

https://doi.org/10.1182/blood.V124.21.1296.1296

Published: 2014

Journal Articles

Serum Uric Acid Levels during Allogeneic Hematopoeitic Cell Transplantation and Subsequent Graft Versus Host Disease

Albert C Yeh, MD, Thomas R. Spitzer, MD, Yi-Bin Chen, MD, Steven McAfee, MD, Karen K. Ballen, MD, Eyal C. Attar, MD, Amir T. Fathi, MD, Bimalangshu R. Dey, MD PhD

Blood (2014) 124 (21): 2493.

https://doi.org/10.1182/blood.V124.21.2493.2493

Published: 2014

Journal Articles

Cardiac Transplant Followed by High-Dose Melphalan and Autologous Stem Cell Transplantation (ASCT) for Patients with AL Amyloidosis and Severe Heart Failure.

Bimalangshu R. Dey, MD, PhD, Thomas R. Spitzer, MD, Thomas E. MacGillivray, MD, Stephen S. Chung, MD, G.W. Dec, MD, David C. Seldin, MD, Steven L. McAfee, MD, Karen Ballen, MD, Eyal Attar, MD, Martha Skinner, MD, Joren C. Madsen, MD, DPhil, Marc J. Semigran, MD

Blood (2007) 110 (11): 732.

https://doi.org/10.1182/blood.V110.11.732.732

Published: 2007

Journal Articles

The Type of Upfront Induction Therapy for Newly Diagnosed Multiple Myeloma Patients Has No Significant Impact on Clinical Outcomes after Autologous Hematopoietic Stem Cell Transplantation.

Stephen S. Chung, MD, Thomas R. Spitzer, MD, David T. Ting, MD, Christine Dube, Andrew J. Yee, MD, Karen Ballen, MD, Steven L. McAfee, MD, Eyal Attar, MD, Bimalangshu R. Dey, MD, PhD

Blood (2007) 110 (11): 5128.

https://doi.org/10.1182/blood.V110.11.5128.5128

Published: 2007

Journal Articles

Non-Myeloablative T-Cell Depleted (TCD) Haploidentical Hematopoietic Cell Transplantation (HCT) Followed by Donor Leukocyte Infusion(s) for Hematologic Malignancies: The MGH Experience.

Bimalangshu R. Dey, MD, PhD, Andrew J. Yee, MD, Steven McAfee, MD, Christine Dube, Karen Ballen, MD, Eyal Attar, MD, Christine Colby, Susan Saidman, PhD, Karen Malikowski, Frederic Preffer, PhD, Megan Sykes, MD, Thomas R. Spitzer, MD

Blood (2007) 110 (11): 5088.

https://doi.org/10.1182/blood.V110.11.5088.5088

Published: 2007

Journal Articles

Impaired Immune Reconstitution after Cord Blood Transplantation in Adults Is Associated with Delayed Recovery but Not Functional Impairment of CD8 + T Cells.

Julia Brown, PhD, Karen Ballen, MD, Sean McDonough, Xupeng Ge, MD, PhD, Kristen Stevenson, PhD, Haesook Kim, PhD, Carol Reynolds, Bimalangshu R. Dey, MD, PhD, Steve McAfee, MD, Eyal Attar, MD, Thomas Spitzer, MD, Corey Cutler, MD, Vincent Ho, MD, Edwin Alyea, MD, Robert Soiffer, MD, Joseph H. Antin, MD, Jerome Ritz, MD, Vassiliki A. Boussiotis, MD, PhD

Blood (2007) 110 (11): 1057.

https://doi.org/10.1182/blood.V110.11.1057.1057

Published: 2007

Journal Articles

KIR Ligand Incompatibility in HLA-Identical Sibling Nonmyeloablative Hematopoietic Stem Cell Transplantation for Hematologic Malignancies.

Jae H. Park, MD, Andrew J. Yee, MD, Thomas R. Spitzer, MD, Susan L. Saidman, PhD, David T. Ting, MD, Andrea Pannone, Jessica Reid, Steven McAfee, MD, Bimalangshu R. Dey, MD, PhD

Blood (2006) 108 (11): 5371.

https://doi.org/10.1182/blood.V108.11.5371.5371

Published: 2006

NARROW

Phase I Study of Bortezomib Combined with Lenalidomide for Relapsed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Following Hematopoietic Cell Transplantation

Bortezomib-Based Versus Standard of Care Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation: A Phase II Randomized Controlled Trial

Hematopoietic Stem Cell Transplantation in the Resource-Limited Setting: Establishing the First Bone Marrow Transplant Unit in Bangladesh and Initial Outcomes

Hematopoeitic Stem Cell Transplantation in the Developing World: A Case Study of Dhaka Medical College, Bangladesh

Prognostic Understanding, Quality of Life, and Mood in Patients Undergoing Hematopoietic Stem Cell Transplantation

Serum Uric Acid Levels during Allogeneic Hematopoeitic Cell Transplantation and Subsequent Graft Versus Host Disease

Cardiac Transplant Followed by High-Dose Melphalan and Autologous Stem Cell Transplantation (ASCT) for Patients with AL Amyloidosis and Severe Heart Failure.

The Type of Upfront Induction Therapy for Newly Diagnosed Multiple Myeloma Patients Has No Significant Impact on Clinical Outcomes after Autologous Hematopoietic Stem Cell Transplantation.

Non-Myeloablative T-Cell Depleted (TCD) Haploidentical Hematopoietic Cell Transplantation (HCT) Followed by Donor Leukocyte Infusion(s) for Hematologic Malignancies: The MGH Experience.

Impaired Immune Reconstitution after Cord Blood Transplantation in Adults Is Associated with Delayed Recovery but Not Functional Impairment of CD8 + T Cells.

KIR Ligand Incompatibility in HLA-Identical Sibling Nonmyeloablative Hematopoietic Stem Cell Transplantation for Hematologic Malignancies.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only